Bivictrix Therapeutics PLC on Wednesday - Macclesfield, England-based biotechnology company focusing on cancer therapies - Announces a proposed fundraise of over GBP2 million by way of a conditional.
Bivictrix Therapeutics PLC on Wednesday said it has raised GBP2.1 million through a placing and subscription of 16.4 million shares.
Earlier on Wednesday, the Macclesfield, England-based.
UPDATE: Bivictrix Therapeutics raises GBP2.1 million through fundraise lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.
By Joe Hoppe BiVictriX Therapeutics said Monday that it has received positive final data from a second in vivo efficacy study of its lead clinical candidate,.